146 related articles for article (PubMed ID: 23886684)
21. Structure and function of non-native metal clusters in human arginase I.
D'Antonio EL; Hai Y; Christianson DW
Biochemistry; 2012 Oct; 51(42):8399-409. PubMed ID: 23061982
[TBL] [Abstract][Full Text] [Related]
22. 2-aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase I.
Ilies M; Di Costanzo L; North ML; Scott JA; Christianson DW
J Med Chem; 2010 May; 53(10):4266-76. PubMed ID: 20441173
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8.
Ilies M; Dowling DP; Lombardi PM; Christianson DW
Bioorg Med Chem Lett; 2011 Oct; 21(19):5854-8. PubMed ID: 21875805
[TBL] [Abstract][Full Text] [Related]
24. Arginase Inhibitors: A Rational Approach Over One Century.
Pudlo M; Demougeot C; Girard-Thernier C
Med Res Rev; 2017 May; 37(3):475-513. PubMed ID: 27862081
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of Leishmania mexicana arginase complexed with α,α-disubstituted boronic amino-acid inhibitors.
Hai Y; Christianson DW
Acta Crystallogr F Struct Biol Commun; 2016 Apr; 72(Pt 4):300-6. PubMed ID: 27050264
[TBL] [Abstract][Full Text] [Related]
26. Chronic oral administration of the arginase inhibitor 2(S)-amino-6-boronohexanoic acid (ABH) improves erectile function in aged rats.
Segal R; Hannan JL; Liu X; Kutlu O; Burnett AL; Champion HC; Kim JH; Steppan J; Berkowitz DE; Bivalacqua TJ
J Androl; 2012; 33(6):1169-75. PubMed ID: 22492840
[TBL] [Abstract][Full Text] [Related]
27. Structural insights into Entamoeba histolytica arginase and structure-based identification of novel non-amino acid based inhibitors as potential antiamoebic molecules.
Malik A; Dalal V; Ankri S; Tomar S
FEBS J; 2019 Oct; 286(20):4135-4155. PubMed ID: 31199070
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of Schistosoma mansoni arginase, a potential drug target for the treatment of schistosomiasis.
Hai Y; Edwards JE; Van Zandt MC; Hoffmann KF; Christianson DW
Biochemistry; 2014 Jul; 53(28):4671-84. PubMed ID: 25007099
[TBL] [Abstract][Full Text] [Related]
29. Boronic acid-based arginase inhibitors in cancer immunotherapy.
Borek B; Gajda T; Golebiowski A; Blaszczyk R
Bioorg Med Chem; 2020 Sep; 28(18):115658. PubMed ID: 32828425
[TBL] [Abstract][Full Text] [Related]
30. Nanomolar inhibitors of AmpC beta-lactamase.
Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F
J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668
[TBL] [Abstract][Full Text] [Related]
31. Boron-Based Drug Design.
Ban HS; Nakamura H
Chem Rec; 2015 Jun; 15(3):616-35. PubMed ID: 25800654
[TBL] [Abstract][Full Text] [Related]
32. A new chromophoric assay for arginase activity.
Baggio R; Cox JD; Harper SL; Speicher DW; Christianson DW
Anal Biochem; 1999 Dec; 276(2):251-3. PubMed ID: 10603248
[No Abstract] [Full Text] [Related]
33. Molecular modeling of Helicobacter pylori arginase and the inhibitor coordination interactions.
Azizian H; Bahrami H; Pasalar P; Amanlou M
J Mol Graph Model; 2010 Apr; 28(7):626-35. PubMed ID: 20080052
[TBL] [Abstract][Full Text] [Related]
34. Discovery of new heterocycles with activity against human neutrophile elastase based on a boron promoted one-pot assembly reaction.
Montalbano F; Cal PM; Carvalho MA; Gonçalves LM; Lucas SD; Guedes RC; Veiros LF; Moreira R; Gois PM
Org Biomol Chem; 2013 Jul; 11(27):4465-72. PubMed ID: 23715243
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.
Watanabe T; Abe H; Momose I; Takahashi Y; Ikeda D; Akamatsu Y
Bioorg Med Chem Lett; 2010 Oct; 20(19):5839-42. PubMed ID: 20727746
[TBL] [Abstract][Full Text] [Related]
37. Boroalkyl group migration provides a versatile entry into α-aminoboronic acid derivatives.
He Z; Zajdlik A; St Denis JD; Assem N; Yudin AK
J Am Chem Soc; 2012 Jun; 134(24):9926-9. PubMed ID: 22662871
[TBL] [Abstract][Full Text] [Related]
38. Increased arginase activity contributes to airway remodelling in chronic allergic asthma.
Maarsingh H; Dekkers BG; Zuidhof AB; Bos IS; Menzen MH; Klein T; Flik G; Zaagsma J; Meurs H
Eur Respir J; 2011 Aug; 38(2):318-28. PubMed ID: 21310883
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and evaluation of new type of L-amino acids containing pyridine moiety as nitric oxide synthase inhibitor.
Ijuin R; Umezawa N; Higuchi T
Bioorg Med Chem; 2006 May; 14(10):3563-70. PubMed ID: 16466923
[TBL] [Abstract][Full Text] [Related]
40. Small-molecule arginase inhibitors.
Ivanenkov YA; Chufarova NV
Pharm Pat Anal; 2014 Jan; 3(1):65-85. PubMed ID: 24354980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
